{"database":"ecrin-mdr-crc","file_versions":[],"scores":null,"additional":{"omics_type":["Clinical"],"study_start_year":["2006"],"condition":["Neoplasm Metastasis","Colorectal cancer","Colorectal Neoplasms","Liver Neoplasms","Neoplasms"],"disease":["Neoplasm Metastasis","Colorectal Cancer","Colorectal Neoplasms","Liver Neoplasms","Neoplasms"],"study_type":["Interventional"],"full_dataset_link":["https://newmdr.ecrin.org/Study/2122780"],"location":["China"],"study_start_month":["9"],"keyword":["Chemotherapy","Cetuximab","Liver metastasis"],"repository":["ECRIN MDR"],"study_status":["Not provided"],"additional_accession":[]},"is_claimable":false,"name":"Cetuximab in Combination With Chemotherapy for the Treatment of Metastatic Colorectal Cancer","description":"In this study, the investigators assessed the effect of Cetuximab in combination with chemotherapy in the treatment of unresectable metastatic colorectal cancer.","dates":{"creation":"2006-09-15"},"accession":"2122780","cross_references":{"ClinicalTrials___gov":["NCT01564810"]}}